RedHill Biopharma erhält FDA-Genehmigung für eine klinische Studie in den USA zur Untersuchung von Opaganib für die Behandlung von COVID-19-Patienten

Daniel Sontupe
Market Access

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

Suma Ramadas, PhD
Medical Affairs

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

David Linetsky
Point-of-Care Marketing